- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00708032
Clinical Performance of a New Daily Disposable Contact Lens Worn in a Neophyte Population.
December 3, 2019 updated by: Johnson & Johnson Vision Care, Inc.
This study seeks to evaluate the impact of wearing a new daily disposable soft contact lens on the neophyte population.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
74
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Greater Manchester
-
Manchester, Greater Manchester, United Kingdom, M60 1QD
- Eurolens Research, The University of Manchester
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 39 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- They are of legal age (18 years) and capacity to volunteer.
- They understand their rights as a research subject and are willing to sign a Statement of Informed Consent.
- They are willing and able to follow the protocol.
- They would be expected to attain at least 6/9 (20/30) in each eye with the study lenses.
- They are able to wear contact lenses with a back vertex power of -1.00 to -6.00DS.
- They have a maximum of 1.00D of refractive astigmatism (i.e. ≤ 1.00 DC).
- They have successfully worn contact lenses within six months of starting the study.
Exclusion Criteria:
- They have an ocular disorder which would normally contra-indicate contact lens wear.
- They have a systemic disorder which would normally contra-indicate contact lens wear.
- They are using any topical medication such as eye drops or ointment.
- They are aphakic.
- They have had corneal refractive surgery.
- They have any corneal distortion resulting from previous hard or rigid lens wear or has keratoconus.
- They are pregnant or lactating.
- They have grade 2 or greater of any of the following ocular surface signs: corneal oedema, corneal vascularisation, corneal staining, tarsal conjunctival changes or any other abnormality which would normally contraindicate contact lens wear.
- They have any infectious disease (e.g. hepatitis) or any immunosuppressive disease (e.g. HIV).
- They have diabetes.
- They have taken part in any other clinical trial or research, within two weeks prior to starting this study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: spectacles
habitual spectacles worn daily for 12 months
|
habitual spectacles
|
Experimental: narafilcon A soft contact lenses
narafilcon A soft contact lenses worn as daily disposable for 12 months
|
narafilcon A daily disposable contact lenses
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Papillary Conjunctivitis
Time Frame: 12 months
|
Papillary conjunctivitis which is collected as part of the biomicroscopy data and is identified from a slit lamp examination.
Grade 0 to Grade 4 with grade 0 implying no health concerns.
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Biomicroscopy Findings After 12 Months of Daily Wear From Slit Lamp Analysis.
Time Frame: at 12 months
|
Comprised of 8 categories (conjunctival hyperemia, limbal hyperemia, corneal vascularization, microcysts, Oedema, corneal staining, conjunctival staining and papillary conjunctivitis) each scored on a scale of 0 to 4 where 0=none, and 4=maximum score for each category.
|
at 12 months
|
Visual Acuity After 12 Months of Wear
Time Frame: at 12 months
|
Visual acuity is measured at high and low contrasts, via the Snellen scale which is then mathematically converted to logMar units.
High contrast refers to a darker print on the Snellen chart and is an easier testing environment compared to the low contrast which has a grayer print.
|
at 12 months
|
Subjective Overall Comfort After 12 Months of Daily Wear
Time Frame: at 12 months
|
subject response using a scale of 0 to 100, where 0 = poor comfort, 100 = excellent comfort
|
at 12 months
|
Subjective Overall Vision After 12 Months of Daily Wear
Time Frame: at 12 months
|
subject response using a scale of 0 to 100, where 0 = poor vision, 100 = excellent vision
|
at 12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2008
Primary Completion (Actual)
December 1, 2009
Study Completion (Actual)
December 1, 2009
Study Registration Dates
First Submitted
June 27, 2008
First Submitted That Met QC Criteria
June 27, 2008
First Posted (Estimate)
July 2, 2008
Study Record Updates
Last Update Posted (Actual)
December 10, 2019
Last Update Submitted That Met QC Criteria
December 3, 2019
Last Verified
November 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CR-0806
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Refractive Error
-
Alcon ResearchCompletedRefractive Error - Myopia Severe | Refractive Error - Myopia SimpleUnited States, Ireland, Singapore
-
Vision Service PlanCompletedRefractive Error - Myopia BilateralUnited States
-
Johnson & Johnson Vision Care, Inc.TerminatedRefractive Error CorrectionUnited States
-
Vision Service PlanCompletedRefractive Error - Myopia BilateralUnited States
-
Wang HongxiaTianjin Eye HospitalCompletedRefractive Error - Myopia AxialChina
-
Tianjin Eye HospitalRecruitingMyopia; Refractive ErrorChina
-
Abbott Medical OpticsCompletedStable Myopic Refractive Error, With or Without AstigmatismUnited States
-
KK Women's and Children's HospitalWithdrawnRefractive Error - Myopia
-
Alcon ResearchCompletedRefractive ErrorsUnited States
-
Alcon ResearchCompletedRefractive ErrorsUnited States
Clinical Trials on spectacles
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityUnknown
-
Johns Hopkins UniversityNational Health and Medical Research Council, AustraliaCompletedAstigmatism | Myopia | HyperopiaChina, India
-
Essilor InternationalQueensland University of TechnologyCompleted
-
Avulux, Inc.Completed
-
Shanghai Eye Disease Prevention and Treatment CenterBrien Holden VisionRecruitingBlindness,Visual Impairment, Refractive Error, Cataract, High Myopia, AgingChina
-
Coopervision, Inc.CompletedAmetropiaUnited Kingdom
-
London School of Hygiene and Tropical MedicineBritish Council for Prevention of Blindness; Tanzanian Society for the BlindCompletedUnder- and Uncorrected Significant Refractive ErrorsTanzania
-
Centre for Eye and Vision ResearchThe Hong Kong Polytechnic University; University of WaterlooRecruiting
-
Queen's University, BelfastUniversity of Ulster; University of Zimbabwe; L.V. Prasad Eye Institute; Clearly; New England College of Optometry and other collaboratorsCompletedHyperopia | Long SightZimbabwe